Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery - Centre de Recherche en Cancérologie de Marseille Accéder directement au contenu
Article Dans Une Revue Frontiers in Immunology Année : 2022

Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery

Résumé

An increasing number of studies have provided strong evidence that gut microbiota interact with the immune system and stimulate various mechanisms involved in the pathogenesis of auto-immune diseases such as Systemic Lupus Erythematosus (SLE). Indeed, gut microbiota could be a source of diagnostic and prognostic biomarkers but also hold the promise to discover novel therapeutic strategies. Thus far, specific SLE microbial signatures have not yet been clearly identified with alteration patterns that may vary between human and animal studies. In this study, a comparative analysis of a clinically well-characterized cohort of adult patients with SLE showed reduced biodiversity, a lower Firmicutes/Bacteroidetes ( F/B ) ratio, and six differentially abundant taxa compared with healthy controls. An unsupervised clustering of patients with SLE patients identified a subgroup of patients with a stronger alteration of their gut microbiota. Interestingly, this clustering was strongly correlated with the disease activity assessed with the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score ( p = 0.03 , odd ratio = 15) and the identification of specific alterations involving the F/B ratio and some different taxa. Then, the gut microbiota of pristane-induced lupus and control mice were analyzed for comparison with our human data. Among the six differentially abundant taxa of the human disease signature, five were common with our murine model. Finally, an exhaustive cross-species comparison between our data and previous human and murine SLE studies revealed a core-set of gut microbiome species that might constitute biomarker panels relevant for future validation studies.
Fichier principal
Vignette du fichier
fimmu-13-943241.pdf (3.15 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03941998 , version 1 (16-01-2023)

Licence

Paternité

Identifiants

Citer

Eya Toumi, Benoit Goutorbe, Anne Plauzolles, Marion Bonnet, Soraya Mezouar, et al.. Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery. Frontiers in Immunology, 2022, 13, ⟨10.3389/fimmu.2022.943241⟩. ⟨hal-03941998⟩
49 Consultations
29 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More